NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
USPS Amid a Plan to Transform and Secure Mail Operations
CIO Pritha Mehra shares how the Postal Service is bringing its technology and systems up to date.
27m listen -
White House Science Advisors Tout Advances in AI Research
Six months after the AI executive order, National Science Foundation and the White House released key AI research and development updates.
3m read -
Spain’s Cyber Agency is Incubating Businesses to Protect NATO Cyberspace
INCIBE Secretary General Carla Redondo Galbarriatu said the private sector is key to strengthening cybersecurity.
12m listen -
DHS AI Board Sees Civil Rights as ‘Part and Parcel’ of AI Safety
Secretary Alejandro Mayorkas shared details about the new board's first meeting and how he sees it transforming the agency's AI development.
3m read
